Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Merus NV - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MRUS
Nasdaq
8731
https://merus.nl/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Merus NV
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024
- Apr 8th, 2024 4:00 pm
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 3rd, 2024 12:00 pm
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
- Mar 20th, 2024 11:37 am
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
- Mar 6th, 2024 1:00 pm
Gilead bets on ‘trispecifics’ in latest cancer drug deal
- Mar 6th, 2024 11:15 am
Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression
- Mar 5th, 2024 9:30 pm
Merus Full Year 2023 Earnings: Misses Expectations
- Mar 5th, 2024 6:49 pm
Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference
- Mar 4th, 2024 1:00 pm
Earnings Update: Merus N.V. (NASDAQ:MRUS) Just Reported And Analysts Are Trimming Their Forecasts
- Mar 2nd, 2024 12:36 pm
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
- Feb 28th, 2024 9:15 pm
Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Feb 20th, 2024 3:00 pm
15 Top Performing European Stocks So Far in 2024
- Feb 16th, 2024 8:57 am
Merus (NASDAQ:MRUS) Is In A Good Position To Deliver On Growth Plans
- Feb 5th, 2024 1:25 pm
Merus to Participate in Upcoming Investor Conferences
- Jan 31st, 2024 1:00 pm
Prothena (PRTA) Surges 12.3%: Is This an Indication of Further Gains?
- Jan 10th, 2024 10:38 am
Merus N.V. (NASDAQ:MRUS) Shares Could Be 44% Below Their Intrinsic Value Estimate
- Jan 9th, 2024 10:22 am
Merus N.V. (MRUS) Surges 16.3%: Is This an Indication of Further Gains?
- Jan 9th, 2024 10:07 am
Wall Street Analysts See a 52.96% Upside in Merus N.V. (MRUS): Can the Stock Really Move This High?
- Dec 28th, 2023 2:55 pm
Wall Street Analysts Think Merus N.V. (MRUS) Could Surge 87.71%: Read This Before Placing a Bet
- Dec 12th, 2023 2:55 pm
Merus N.V. (MRUS) Moves to Buy: Rationale Behind the Upgrade
- Dec 5th, 2023 5:00 pm
Scroll